Profile
Gabriel M.
Cohn worked as the Medical Director & Head-Clinical Division at Baystate Medical Center from 1993 to 2008.
He also worked as the Director-Reproductive Genetics at State University of New York at Downstate Medical Center in 1992.
Later, he worked as the Senior Medical Director-Clinical Sciences at Shire Human Genetic Therapies, Inc. and as the VP, Head-Global Clinical & Medical Affairs at OvaScience, Inc. from 2015 to 2017.
He served as the Chief Medical Officer at Homology Medicines, Inc. and as the Vice President-Clinical Development at Avrobio, Inc. from 2017 to 2019.
Dr. Cohn completed his undergraduate degree from Brooklyn College in 1980, his doctorate from SUNY Upstate Medical University in 1986, and his MBA from the University of Massachusetts in 2006.
Former positions of Gabriel Cohn
| Companies | Position | End |
|---|---|---|
| AVROBIO, INC. | Chief Tech/Sci/R&D Officer | 2019-11-30 |
OvaScience, Inc.
 OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Chief Tech/Sci/R&D Officer | 2017-06-30 |
Baystate Medical Center
 Baystate Medical Center Hospital/Nursing ManagementHealth Services Baystate Medical Center provides health care services. It offers cardiology, cancer treatment, surgery, and women's health care services. The firm serves the Western Campus of Tufts University School of Medicine in western Massachusetts. The company is headquartered in Springfield, MA. | Chief Tech/Sci/R&D Officer | 2007-12-31 |
| State University of New York at Downstate Medical Center | Corporate Officer/Principal | 1993-08-31 |
Shire Human Genetic Therapies, Inc.
 Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Corporate Officer/Principal | - |
Training of Gabriel Cohn
| SUNY Upstate Medical University | Doctorate Degree |
| Brooklyn College | Undergraduate Degree |
| University of Massachusetts | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| AVROBIO, INC. | Health Technology |
| Private companies | 4 |
|---|---|
OvaScience, Inc.
OvaScience, Inc. Pharmaceuticals: MajorHealth Technology OvaScience, Inc. engages in the research and development of female infertility treatments. Its portfolio includes AUGMENT, OvaPrime, OvaTure, and OvaXon which intends to improve the female's egg health and reserve. The company was founded by Rich H. Aldrich, Michelle Dipp, Jonathan L. Tilly, and Christoph H. Westphal on April 5, 2011 and is headquartered in Waltham, MA. | Health Technology |
Homology Medicines, Inc.
 Homology Medicines, Inc. Pharmaceuticals: MajorHealth Technology Homology Medicines, Inc. is a clinical-stage genetic medicines company, which engages in the translation of proprietary gene editing and gene therapy technology into novel treatments for patients with rare genetic diseases. The company was founded in March 2015 and is headquartered in Bedford, MA. | Health Technology |
Baystate Medical Center
Baystate Medical Center Hospital/Nursing ManagementHealth Services Baystate Medical Center provides health care services. It offers cardiology, cancer treatment, surgery, and women's health care services. The firm serves the Western Campus of Tufts University School of Medicine in western Massachusetts. The company is headquartered in Springfield, MA. | Health Services |
Shire Human Genetic Therapies, Inc.
Shire Human Genetic Therapies, Inc. Medical SpecialtiesHealth Technology Shire Human Genetic Therapies, Inc. develops medicines for the treatment of genetic diseases. The company was founded on July 7, 1988 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Gabriel Cohn
